IB Acquisition Corp. — Form 10-Q Summary
Reporting period: Fiscal quarter and six months ended March 31, 2024 (fiscal Q2, despite the request metadata’s calendar-quarter label). The filing was signed May 15, 2024. IB Acquisition is a blank-check company and had not selected a business-combination target or begun substantive discussions with a potential target as of March 31.
Financial results and position
| Metric | Three months ended March 31, 2024 | Six months ended March 31, 2024 |
|---|---|---|
| Operating revenue | None | None |
| General and administrative expense | $194,646 | $282,137 |
| Net loss | $194,646 | $282,137 |
| Basic loss per share | $0.06 for redeemable and non-redeemable shares | $0.09 for redeemable and non-redeemable shares |
- At March 31, cash outside the trust was $1,661,315; cash in the trust account was $115,575,000. Current assets were $1,690,378 and current liabilities were $336,744, leaving working capital of $1,353,634.
- Six-month operating cash use was $181,868. Investing cash use was $115,575,000, principally the trust deposit; financing cash inflow was $117,365,630. Ending cash outside the trust was $1,661,315.
- There was no debt reported. The trust held cash and had earned no interest withdrawn by March 31. The filing reports no operating revenue and does not provide a meaningful operating margin.
- IPO and private-placement proceeds: the March 28 IPO raised $115 million gross from 11.5 million units; the sponsor separately purchased 610,500 private-placement units for $6.105 million. Reported offering transaction costs were $7,755,845.
Changes versus the prior comparable period
Compared with the three and six months ended March 31, 2023, expenses and losses increased from $48 and $96, respectively, as the company completed its IPO in March 2024 and incurred public-company and acquisition-related costs. The prior-year periods had no trust balance; the $115.575 million trust account was funded upon the IPO. The company had no operating revenue in either period.
Outlook, risks, and unusual items
- Management expects significant ongoing acquisition-search costs and does not expect operating revenue before a business combination. The company has 18 months from the IPO closing to complete a business combination; otherwise, it must redeem public shares and liquidate, subject to the filing’s terms.
- Management concluded that available liquidity is insufficient to sustain operations for at least one year from issuance of the financial statements, raising substantial doubt about the company’s ability to continue as a going concern. Management expects a business combination to address this, but gives no assurance its plans will succeed within the combination period.
- The company expects to use trust funds primarily for a business combination. Trust funds are restricted, apart from permitted tax withdrawals; they should not be treated as ordinary operating cash. Public shareholders generally may redeem shares in connection with a transaction. The filing states a minimum $5,000,001 net tangible asset requirement at closing.
- A $4.025 million marketing fee is payable to I-Bankers only if a business combination closes; an additional finder fee of 1% of consideration may apply for a target introduced by I-Bankers. Sponsor working-capital loans are possible but not committed.
- The filing states disclosure controls and procedures were not effective at a reasonable assurance level. The related sentence then says they “accordingly, provided reasonable assurance,” an apparent internal inconsistency that investors should review.
- No material changes to the IPO prospectus risk factors were reported. The company cited uncertainty from global conflicts and related sanctions, with impacts not determinable. No legal proceedings or subsequent events requiring adjustment or disclosure were identified.
Important facts for investors to verify
- Whether the company has since identified a target, entered substantive discussions, or obtained additional financing; the filing reported no target selected as of March 31.
- The business-combination deadline and redemption/liquidation terms, including the amount ultimately available per public share and the effect of redemptions on transaction funding.
- Liquidity outside the trust, expected operating costs, and the going-concern uncertainty; trust cash is restricted.
- The disclosure-controls conclusion and its inconsistent wording, and any remediation or subsequent control changes.
- Potential transaction-related payments, including the $4.025 million marketing fee and any applicable finder fee.